IL6 and neoplasm: Conversely, inhibitory tumor‐type CAFs can negatively regulate tumor T cell responses by secreting immunosuppressive factors such as interleukin‐6 (IL‐6) and tumor necrosis factor‐alpha, or by promoting the recruitment of myeloid‐derived suppressor cells.